Skip to main content

John Schneider, Peter Barrett

John Schneider has joined Vitra Bioscience as vice president of marketing and business development.

Prior to joining Vitra, Schneider held roles of R&D director and VP of marketing and business development at Molecular Dynamics and Amersham Biosciences, both of which were acquired last year by GE Healthcare.


Peter Barrett has been named chairman of the board of directors of Momenta Pharmaceuticals. Barrett previously served as executive vice president and chief business officer of Celera Genomics, and before that in senior management positions at Applera. He currently is a senior partner at Atlas Venture.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.